Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial

BACKGROUND: Hypofractionated palliative radiotherapy for metastatic lung cancer patients is frequently used in order to ease pain, to increase bone stability, to treat local mass effects, or to prolong progression-free survival at critical sites. Recently introduced, immunotherapy for patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Bozorgmehr, Farastuk, Hommertgen, Adriane, Krisam, Johannes, Lasitschka, Felix, Kuon, Jonas, Maenz, Martin, Huber, Peter E., König, Laila, Kieser, Meinhard, Debus, Juergen, Thomas, Michael, Rieken, Stefan
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6842256/
https://ncbi.nlm.nih.gov/pubmed/31703637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6205-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados